Uncategorized - Part 2

US stocks advance amid corporate earnings, consumer confidence rises

January 29, 2014 7:45 am

US stocks snapped 3-day drop as the Standard & Poor’s 500 Index rebounded from its worst slump since June, as earnings at companies topped estimates and consumer confidence gained of a Federal Reserve policy meeting. The S&P 500 added 0.6% to 1,792.50 at 4 p.m. in New York. The Dow Jones Industrial Average climbed 90.68 […] Read more

US stocks decline the most since August amid tapering speculation

December 14, 2013 12:11 pm

US stocks declined the most on weekly basis since August, pulling the Standard & Poor’s 500 Index down from a record high, as investors weighed prospects for Fed tapering amid improving US economic data. The S&P 500 fell 1.6% to 1,775.32 for the week after closing at an all-time high of 1,808.37 on December 9th. […] Read more

US stock-index futures signal S&P 500 may continue its record run

November 29, 2013 12:44 pm

US stocks-index futures rose, signaling the Standard & Poor’s 500 Index futures will extend a record after yesterday’s Thanksgiving holiday, as most European stocks advanced. S&P 500 futures climbed 0.2% at 10:23 a.m. London time and the Stoxx Europe 600 Index was little changed. Dow Jones average soared 0.2% to 16,109 while Nasdaq technology index […] Read more

European stocks open lower, China drives Asian shares up

November 18, 2013 9:58 am

European stocks decline during first minutes of trading, after the Stoxx Europe 600 Index rose last week wrapping up the longest winning streak in 15 months, as China committed to carry out the broadest plan for economic reform at least since 1990 which boosted Asian shares. The Stoxx 600 lost 0.2% to 322.22 at 9:40 […] Read more

US stocks increase as Yellen commits to stimulus

November 15, 2013 8:02 am

US stocks advanced, extending benchmark indexes to fresh records, as comments from Janet Yellen signaled she will continue the Federal Reserve’s stimulus efforts amid negative jobless claims data and trade balance. The Standard & Poor’s 500 Index rose 0.5% to a record 1,790.62 at 4 p.m. in New York. The Dow Jones Industrial Average added […] Read more

Adidas to revive Reebok with re-branding to fitness equipment

October 1, 2013 7:26 am

Reebok is attracting sponsorship deals with prominent fitness groups to try to revive name that has faded since it became part of Germanys Adidas sportswear group eight years ago. The sports shoe and clothing brand is winning followers among hardcore sports enthusiasts and aims to build on this support to make up ground it has […] Read more

US stock index futures almost unchanged

September 24, 2013 1:02 pm

U.S. stock-index futures were little changed, after a three-day decline by the Standard & Poor’s 500 Index, as investors awaited a report on consumer confidence and weighed comments by Federal Reserve officials. S&P 500 futures expiring in December slipped less than 0.1% to 1,692 at 8:50 a.m. in New York. The benchmark gauge for U.S. […] Read more

Twitter files documents for IPO under JOBS act

September 13, 2013 7:05 am

Twitter Inc., the microblogging social site with more than 200 million members worldwide, filed to go public, moving closer to the most highly anticipated offering since Facebook Inc. “We’ve confidentially submitted an S1 to the SEC for a planned IPO. This Tweet does not constitute an offer of any securities for sale,” the messaging site […] Read more

US stocks advance amid Syria vote, economic data

September 4, 2013 2:35 pm

US stocks rose, extending a one-week high, before a Senate committee vote on action against Syria as investors awaited economic data for clues on the Federal Reserve’s next move. The Standard & Poor’s 500 Index rose 0.3% to 1,644.63 at 10:00 a.m. in New York. The Dow Jones Industrial Average added 48.30 points, or 0.3%, […] Read more

New medicine lacks competition, Novatris profit forecast raise

July 17, 2013 8:54 am

The Europes biggest drug-maker raised its profit and sales forecasts as generic competition for the Diovan blood-pressure medicine failed to materialize in the U.S. This means earnings will fall by a lower percentage this year, while sales will climb by similar amount, both excluding currency swings, Switzerland-based company said in a statement today. Novartis previously […] Read more